Abstract
Methicillin-Resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium which causes community and hospital-acquired infections. Synthetic drug/antibiotic treatment for MRSA-related infections is becoming less effective and natural products may be an emerging new alternative for future antibacterial drug development. Alkaloids are a class of natural compounds which are known for their phytochemistry and pharmacology. This review focuses on 32 alkaloids isolated from various plants that showed marked antibacterial activity against MRSA by acting through different mechanisms such as inhibition of pyruvate kinase, Quorum quenching effect, alteration in efflux pump in MRSA and intercalating of bacterial DNA, to name just a few. In addition, the use of recent plant alkaloids against clinical isolates of MRSA has also been discussed.
Keywords: Alkaloids, MRSA, different susceptibility mechanisms.
Current Pharmaceutical Design
Title:Alkaloids: An Emerging Antibacterial Modality Against Methicillin Resistant Staphylococcus aureus
Volume: 22 Issue: 28
Author(s): Aini Pervaiz, Ruqaiyah Khan, Firoz Anwar, Gohar Mushtaq, Mohammad A. Kamal and Haroon Khan
Affiliation:
Keywords: Alkaloids, MRSA, different susceptibility mechanisms.
Abstract: Methicillin-Resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium which causes community and hospital-acquired infections. Synthetic drug/antibiotic treatment for MRSA-related infections is becoming less effective and natural products may be an emerging new alternative for future antibacterial drug development. Alkaloids are a class of natural compounds which are known for their phytochemistry and pharmacology. This review focuses on 32 alkaloids isolated from various plants that showed marked antibacterial activity against MRSA by acting through different mechanisms such as inhibition of pyruvate kinase, Quorum quenching effect, alteration in efflux pump in MRSA and intercalating of bacterial DNA, to name just a few. In addition, the use of recent plant alkaloids against clinical isolates of MRSA has also been discussed.
Export Options
About this article
Cite this article as:
Pervaiz Aini, Khan Ruqaiyah, Anwar Firoz, Mushtaq Gohar, Kamal A. Mohammad and Khan Haroon, Alkaloids: An Emerging Antibacterial Modality Against Methicillin Resistant Staphylococcus aureus, Current Pharmaceutical Design 2016; 22 (28) . https://dx.doi.org/10.2174/1381612822999160629115627
DOI https://dx.doi.org/10.2174/1381612822999160629115627 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Structural Insights into Chitinolytic Enzymes and Inhibition Mechanisms of Selective Inhibitors
Current Pharmaceutical Design Synthesis, Structure and Antibacterial Evaluation of Some N-substituted 3-amino-5-hydroxy-4-phenyl-1H-pyrazole-1-carboxamides
Medicinal Chemistry Proteomic and Bioinformatics Tools to Understand Virulence Mechanisms in Staphylococcus aureus
Current Proteomics Orchestrating HIV Neutralization by Secondary Immune Response- Mediated Induction of RF Antibodies
Current Immunology Reviews (Discontinued) Computational Modelling of Catalytic Properties and Modified Substrates of Fungal β-N-Acetylhexosaminidases
Mini-Reviews in Organic Chemistry Non-Microbicidal Control of Bacterial Biofilms with Small Molecules
Anti-Infective Agents Inside the Pan-genome - Methods and Software Overview
Current Genomics An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome
Infectious Disorders - Drug Targets Anti-MRSA Cephems: An Update
Current Medicinal Chemistry - Anti-Infective Agents Scintigraphic Imaging of Inflammatory Processes
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Noncardiac Surgery: Evaluating and Minimizing Cardiac Risk
Current Cardiology Reviews Optimal antibiotic dosage for chronic kidney disease patient: a pharmacological manual for oral clinicians
Recent Patents on Anti-Infective Drug Discovery Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Current Cardiology Reviews DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets The Entirely Subcutaneous Defibrillator (S-Icd): State of the Art and Selection of the Ideal Candidate
Current Cardiology Reviews Development of Infection and Inflammation Targeting Compounds
Current Radiopharmaceuticals Use of Oritavancin (Novel New Lipoglycopeptide) in the Treatment of Prosthetic Joint Infections (PJI): A Possible Alternative Novel Approach to a Difficult Problem
Infectious Disorders - Drug Targets Receptor Binding Ligands to Image Infection
Current Pharmaceutical Design Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Acute Phase Treatment of Pulmonary Embolism
Current Vascular Pharmacology